A Study of Elacestrant Alone or in Combination With Abemaciclib in People With Endometrial Cancer
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Fudan University
Mayo Clinic
Abramson Cancer Center at Penn Medicine
Mayo Clinic
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Brigham and Women's Hospital
M.D. Anderson Cancer Center
University of Miami
Dana-Farber Cancer Institute
University of Florida
Mayo Clinic
Centro di Riferimento Oncologico - Aviano
Dana-Farber Cancer Institute
University Hospital Tuebingen
Memorial Sloan Kettering Cancer Center
Hackensack Meridian Health
Memorial Sloan Kettering Cancer Center
Royal North Shore Hospital
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Cukurova University
UNC Lineberger Comprehensive Cancer Center
University of Aarhus
University of Nebraska
Washington University School of Medicine
Gustave Roussy, Cancer Campus, Grand Paris
Imperial College London
M.D. Anderson Cancer Center
Medical College of Wisconsin
Mayo Clinic
Dana-Farber Cancer Institute
Roswell Park Cancer Institute
Memorial Sloan Kettering Cancer Center
Peking University People's Hospital
University of Chicago
Mayo Clinic
Memorial Sloan Kettering Cancer Center
Radboud University Medical Center
Abramson Cancer Center at Penn Medicine
Washington University School of Medicine
Regina Elena Cancer Institute
West China Hospital
University of Alberta
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Mayo Clinic
University of Kentucky
UNC Lineberger Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center